PharmacotherapeuticsjforjAdvancedjPracticejNursejPrescribersj5thjEditionjWoojRobinsonjTestjBank
Chapterj1.jThejRolejofjthejNursejPractitionerj
MultiplejChoice
Identifyj thej choicej thatj bestj completesj thej statementj orj answersj thej question.
about:blank 1/248
,10/9/23,j1:46jAM TESTjBANKjPharmacotherapeuticsjFORjAdvancedjPracticejNursejPrescri…
PharmacotherapeuticsjforjAdvancedjPracticejNursejPrescribersj5thjEditionjWoojRobinsonjTestjBank
Chapterj1.jThejRolejofjthejNursejPractitionerj
MultiplejChoice
Identifyj thej choicej thatj bestj completesj thej statementj orj answersj thej question.
1. Nursejpractitionerj prescriptivej authorityj isj regulatedj by:
1. ThejNationaljCouncilj ofj Statej BoardsjofjNursing
2. Thej U.S.j Drugj Enforcementj Administration
3. ThejStatej BoardjofjNursingj forjeachjstate
4. ThejStatej Boardjofj Pharmacy
2. Thej benefitsj tojthej patientjofj havingjanj AdvancedjPracticej RegisteredjNursej (APRN)j prescriberji
nclude:
1. Nursesjknowj morejaboutjPharmacologyjthanjotherjprescribers jbecausejtheyj takej itjb
othjinjtheirjbasicjnursingjprogramjandjinjtheirjAPRNjprogram.
2. Nursesjcarej forj thejpatientj fromj aj holisticjapproachjandj includejthejpatientj injd
ecisionjmakingjregardingjtheirjcare.
3. APRNsjarej lessj likelyjtojprescribej narcoticsj andjotherjcontrolledjsubstances.
4. APRNsjarejablejtojprescribej independentlyj injalljstates,jwhereasjajphysician’s
assistantj needs jtoj havejajphysicianjsupervisingjtheirjpractice.
3. Clinicalj judgmentj injprescribingj includes:
1. Factoringj inj thejcostjtojthejpatientjofjthej medicationjprescribed
2. Alwaysjprescribingj thej newestj medicationj availablej forj thejdiseasej process
3. Handingjoutjdrugjsamplesjtoj poorjpatients
4. Prescribingjallj genericj medications jtojcutjcosts
4. Criteriaj forjchoosingjanjeffectivejdrugj forjajdisorderj include:
1. Askingjthejpatientjwhatjdrugjtheyj thinkjwouldjworkjbestj forj them
2. Consultingj nationallyj recognizedj guidelinesj forj diseasej management
3. Prescribingj medicationsj thatjarej availablejasj samplesj beforej writingj ajprescription
4. Followingj U.S.j Drugj Enforcementj Administrationj guidelinesj forj prescribing
5. Nursejpractitionerj practicej mayj thrivej underj health-carej reformj becausej of:
1. Thejdemonstratedjabilityjofj nursejpractitionersjtojcontroljcostsjandj improvejpatientjo
utcomes
2. Thej factjthatj nursejpractitionersjwillj bejablejtojpracticej independently
3. Thej factjthatj nursejpractitioners jwillj havej fullj reimbursementj underj health-
carejreform
4. Thejabilityjtojshiftjaccountabilityj forjMedicaidjtojthejstatej level
about:blank 2/248
,10/9/23,j1:46jAM TESTjBANKjPharmacotherapeuticsjFORjAdvancedjPracticejNursejPrescri…
Chapterj1.jThejRolejofjthejNursejPractitionerj
AnswerjSection
MULTIPLEjCHOICE
1.jANS: 3 PTS: 1
2.jANS: 2 PTS: 1
3.jANS: 1 PTS: 1
about:blank 3/248
, 10/9/23,j1:46jAM TESTjBANKjPharmacotherapeuticsjFORjAdvancedjPracticejNursejPrescri…
Chapterj1.jThejRolejofjthejNursejPractitionerj
AnswerjSection
MULTIPLEjCHOICE
1.jANS: 3 PTS: 1
2.jANS: 2 PTS: 1
3.jANS: 1 PTS: 1
4.jANS: 2 PTS: 1
5.jANS: 1 PTS: 1
Chapterj2.jReviewjofjBasicjPrinciplesjofjPharmacologyj
MultiplejChoice
Identifyj thej choicej thatj bestj completesj thej statementj orj answersj thej question.
1. Ajpatient’sjnutritionalj intakejandj laboratoryjresultsjreflectj hypoalbuminemia.j Thisj isjcriticaljto
prescribingj because:
1. Distributionjofjdrugsjtojtargetjtissuej mayjbejaffected.
2. Thejsolubilityjofjthejdrugjwillj notj matchjthejsitejofjabsorption.
3. Therejwilljbej lessj freejdrugjavailablejtojgeneratejanjeffect.
4. Drugsjboundjtojalbuminjarej readilyjexcretedjbyj thejkidneys.
2. Drugsjthatj havejajsignificantj first-passj effect:
1. Mustjbej givenjbyjthejenteralj(oral)jroutejonly
2. Bypassjthej hepaticj circulation
3. Arejrapidlyj metabolizedjbyjthej liverjandj mayj havej littlej ifjanyjdesiredjaction
4. Arejconvertedjbyjthej liverjtoj morejactivejandj fat-solublej forms
3. Thejroutejofjexcretionjofjajvolatilejdrugjwilljlikelyjbej the:
1. Kidneys
2. Lungs
3. Bilejandjfeces
4. Skin
4. Medroxyprogesterone j(Depoj Provera)j isj prescribedj intramuscularlyj (IM)j toj createjaj storagejr
eservoirjofjthejdrug. jStoragejreservoirs:
1. Assurejthatjthejdrugjwilljreachj itsj intendedjtargetjtissue
2. Arejthej reasonj forj givingj loadingjdoses
3. Increasejthej lengthjofjtimejajdrugjisjavailablejandjactive
4. Arej mostjcommonj injcollagenjtissues
5. ThejNPjchoosesjtoj givejcephalexinjeveryj8j hoursjbasedjonjknowledgejofjthej drug’s:
1. Propensityjtoj gojtojthejtargetjreceptor
2. Biologicalj half-life
3. Pharmacodynamics
4. Safetyjandjsidejeffects
6. Azithromycinjdosingjrequiresjthatjthej firstj day’sjdosagejbejtwicej thosejofjthejotherj4jdaysjofj the
prescription.j Thisj isjconsideredjaj loadingjdose.jAj loadingjdose:
1. Rapidlyjachievesj drugj levelsj injthejtherapeuticj range
2. Requiresj four-jtoj five-half-livesjtojattain
3. Isj influencedjbyjrenalj function
4. Isjdirectlyj relatedj tojthej drugjcirculatingj tojthej targetj tissues
7. Thejpointj injtimejonjthejdrugjconcentrationj curvejthatj indicatesjthej firstjsignjofjajtherapeutic jeffectjisj
the:
about:blank 4/248